Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 137 | 2024 | 8984 | 5.270 |
Why?
|
Glioblastoma | 84 | 2024 | 3482 | 5.090 |
Why?
|
Glioma | 71 | 2024 | 3420 | 4.640 |
Why?
|
Astrocytoma | 25 | 2023 | 775 | 2.190 |
Why?
|
Meningioma | 14 | 2022 | 1220 | 1.380 |
Why?
|
Meningeal Neoplasms | 15 | 2022 | 1248 | 1.380 |
Why?
|
Oligodendroglia | 12 | 2020 | 535 | 1.300 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 15 | 2019 | 1137 | 1.100 |
Why?
|
Mutation | 73 | 2024 | 29950 | 1.090 |
Why?
|
PTEN Phosphohydrolase | 11 | 2020 | 1115 | 0.990 |
Why?
|
Central Nervous System Neoplasms | 8 | 2024 | 917 | 0.970 |
Why?
|
Isocitrate Dehydrogenase | 18 | 2024 | 927 | 0.940 |
Why?
|
Dacarbazine | 14 | 2022 | 560 | 0.930 |
Why?
|
DNA Copy Number Variations | 11 | 2022 | 2008 | 0.910 |
Why?
|
Comparative Genomic Hybridization | 13 | 2017 | 473 | 0.890 |
Why?
|
Proto-Oncogene Proteins B-raf | 16 | 2024 | 2052 | 0.890 |
Why?
|
Medulloblastoma | 9 | 2024 | 677 | 0.880 |
Why?
|
Neoplasm Recurrence, Local | 20 | 2024 | 9274 | 0.820 |
Why?
|
Antineoplastic Agents, Alkylating | 10 | 2022 | 619 | 0.820 |
Why?
|
Oligodendroglioma | 11 | 2024 | 279 | 0.790 |
Why?
|
Nerve Tissue Proteins | 12 | 2014 | 4409 | 0.770 |
Why?
|
Single-Cell Analysis | 12 | 2024 | 2368 | 0.770 |
Why?
|
Tumor Suppressor Protein p53 | 16 | 2023 | 2927 | 0.750 |
Why?
|
Aminopyridines | 4 | 2019 | 564 | 0.710 |
Why?
|
Morpholines | 4 | 2019 | 583 | 0.670 |
Why?
|
Oncogene Proteins, Fusion | 11 | 2022 | 1591 | 0.660 |
Why?
|
Cerebellar Neoplasms | 6 | 2024 | 585 | 0.660 |
Why?
|
Phosphatidylinositol 3-Kinase | 2 | 2023 | 126 | 0.660 |
Why?
|
High-Throughput Nucleotide Sequencing | 18 | 2024 | 3618 | 0.650 |
Why?
|
Neural Stem Cells | 7 | 2020 | 884 | 0.650 |
Why?
|
Pineal Gland | 4 | 2019 | 157 | 0.640 |
Why?
|
Brain Stem Neoplasms | 6 | 2022 | 190 | 0.600 |
Why?
|
Genomics | 19 | 2024 | 5790 | 0.600 |
Why?
|
Antineoplastic Agents | 19 | 2023 | 13629 | 0.590 |
Why?
|
Homeodomain Proteins | 7 | 2017 | 2414 | 0.580 |
Why?
|
Cell Lineage | 17 | 2024 | 2525 | 0.580 |
Why?
|
Stem Cells | 9 | 2014 | 3525 | 0.560 |
Why?
|
Gene Expression Regulation, Neoplastic | 27 | 2020 | 8498 | 0.550 |
Why?
|
Oncogenes | 10 | 2022 | 1221 | 0.550 |
Why?
|
Trans-Activators | 4 | 2019 | 2861 | 0.550 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.530 |
Why?
|
Histones | 12 | 2023 | 2583 | 0.530 |
Why?
|
Central Nervous System | 5 | 2022 | 1334 | 0.520 |
Why?
|
Phosphatidylinositol 3-Kinases | 8 | 2023 | 2866 | 0.520 |
Why?
|
Hedgehog Proteins | 5 | 2015 | 769 | 0.520 |
Why?
|
Humans | 252 | 2024 | 760261 | 0.480 |
Why?
|
Cell Line, Tumor | 39 | 2024 | 16905 | 0.470 |
Why?
|
Proto-Oncogene Proteins | 8 | 2022 | 4494 | 0.470 |
Why?
|
Mice | 72 | 2024 | 81216 | 0.460 |
Why?
|
Germinoma | 2 | 2022 | 132 | 0.460 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 9 | 2020 | 698 | 0.450 |
Why?
|
DNA Methylation | 15 | 2023 | 4374 | 0.440 |
Why?
|
Pinealoma | 3 | 2019 | 51 | 0.440 |
Why?
|
Astrocytes | 12 | 2024 | 1335 | 0.430 |
Why?
|
Molecular Targeted Therapy | 8 | 2024 | 2805 | 0.420 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2023 | 2823 | 0.410 |
Why?
|
Rhabdoid Tumor | 3 | 2024 | 210 | 0.410 |
Why?
|
Sequence Analysis, DNA | 10 | 2020 | 4717 | 0.400 |
Why?
|
Receptor, trkB | 3 | 2020 | 125 | 0.400 |
Why?
|
Animals | 87 | 2024 | 167940 | 0.400 |
Why?
|
Chromosomes, Human, Pair 1 | 6 | 2019 | 635 | 0.390 |
Why?
|
Genome, Human | 10 | 2020 | 4416 | 0.390 |
Why?
|
Gene Expression Regulation, Developmental | 9 | 2020 | 3601 | 0.390 |
Why?
|
DNA Modification Methylases | 7 | 2022 | 208 | 0.390 |
Why?
|
Triazoles | 4 | 2024 | 904 | 0.380 |
Why?
|
Glutarates | 5 | 2023 | 244 | 0.380 |
Why?
|
Child | 58 | 2024 | 79758 | 0.370 |
Why?
|
Cell Differentiation | 18 | 2024 | 11480 | 0.370 |
Why?
|
Ependymoma | 3 | 2020 | 320 | 0.350 |
Why?
|
Gene Expression Profiling | 22 | 2021 | 9388 | 0.350 |
Why?
|
Neurons | 10 | 2020 | 9416 | 0.350 |
Why?
|
Forkhead Transcription Factors | 4 | 2022 | 1613 | 0.340 |
Why?
|
Angiomatosis | 1 | 2009 | 46 | 0.320 |
Why?
|
DNA Repair Enzymes | 6 | 2022 | 345 | 0.320 |
Why?
|
Prognosis | 32 | 2024 | 29636 | 0.320 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2018 | 11708 | 0.320 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2019 | 5230 | 0.310 |
Why?
|
Tumor Suppressor Proteins | 9 | 2022 | 2804 | 0.310 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 4573 | 0.310 |
Why?
|
Hydrazines | 2 | 2024 | 224 | 0.310 |
Why?
|
DNA Mutational Analysis | 11 | 2021 | 4109 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-myb | 2 | 2019 | 79 | 0.310 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2020 | 367 | 0.300 |
Why?
|
Gene Dosage | 6 | 2020 | 1218 | 0.300 |
Why?
|
Retinal Neoplasms | 1 | 2009 | 146 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2023 | 3584 | 0.290 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2811 | 0.290 |
Why?
|
Mice, Nude | 12 | 2019 | 3605 | 0.290 |
Why?
|
Retinoblastoma Protein | 1 | 2011 | 671 | 0.290 |
Why?
|
Glycoproteins | 2 | 2014 | 2208 | 0.290 |
Why?
|
Male | 99 | 2024 | 359413 | 0.290 |
Why?
|
Genome-Wide Association Study | 4 | 2017 | 12602 | 0.280 |
Why?
|
Cell Proliferation | 20 | 2024 | 10434 | 0.270 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2013 | 267 | 0.270 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2019 | 114 | 0.260 |
Why?
|
Neoplasms | 10 | 2024 | 22066 | 0.260 |
Why?
|
Immunotherapy | 3 | 2020 | 4637 | 0.260 |
Why?
|
Signal Transduction | 23 | 2020 | 23363 | 0.260 |
Why?
|
Telomerase | 3 | 2023 | 747 | 0.260 |
Why?
|
Female | 97 | 2024 | 391011 | 0.250 |
Why?
|
Pituitary Neoplasms | 4 | 2017 | 1313 | 0.250 |
Why?
|
Child, Preschool | 26 | 2024 | 42034 | 0.250 |
Why?
|
Neoplastic Stem Cells | 5 | 2022 | 1347 | 0.240 |
Why?
|
Tumor Microenvironment | 11 | 2023 | 3826 | 0.240 |
Why?
|
Adult | 61 | 2024 | 219847 | 0.240 |
Why?
|
Neoplasms, Experimental | 5 | 2020 | 1229 | 0.240 |
Why?
|
Antigens, CD | 2 | 2014 | 4002 | 0.230 |
Why?
|
Transcription Factors | 14 | 2024 | 12100 | 0.230 |
Why?
|
RNA-Binding Proteins | 4 | 2017 | 1892 | 0.230 |
Why?
|
Gene Fusion | 2 | 2017 | 354 | 0.220 |
Why?
|
Adolescent | 37 | 2024 | 87747 | 0.220 |
Why?
|
Quinazolines | 4 | 2015 | 1363 | 0.220 |
Why?
|
Aneuploidy | 2 | 2021 | 551 | 0.210 |
Why?
|
Proteoglycans | 1 | 2006 | 802 | 0.210 |
Why?
|
Craniopharyngioma | 2 | 2017 | 277 | 0.210 |
Why?
|
Indoles | 4 | 2015 | 1830 | 0.210 |
Why?
|
Interneurons | 2 | 2020 | 591 | 0.210 |
Why?
|
Embryo, Mammalian | 7 | 2020 | 1667 | 0.210 |
Why?
|
Telencephalon | 1 | 2003 | 142 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 5 | 2023 | 5640 | 0.200 |
Why?
|
Vaccinia | 1 | 2022 | 71 | 0.200 |
Why?
|
Neuroblastoma | 2 | 2022 | 1252 | 0.200 |
Why?
|
Choriocarcinoma | 1 | 2022 | 121 | 0.200 |
Why?
|
Ribonuclease III | 2 | 2022 | 279 | 0.200 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2018 | 807 | 0.200 |
Why?
|
Piperidines | 3 | 2018 | 1650 | 0.200 |
Why?
|
Gliosarcoma | 1 | 2022 | 113 | 0.200 |
Why?
|
Epigenomics | 3 | 2023 | 936 | 0.200 |
Why?
|
Cell Cycle | 6 | 2022 | 2937 | 0.200 |
Why?
|
Middle Aged | 52 | 2021 | 220175 | 0.190 |
Why?
|
Cerebrum | 3 | 2016 | 132 | 0.190 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2022 | 493 | 0.190 |
Why?
|
Meninges | 1 | 2003 | 197 | 0.190 |
Why?
|
Choristoma | 1 | 2003 | 207 | 0.190 |
Why?
|
In Situ Hybridization | 4 | 2014 | 1900 | 0.190 |
Why?
|
DEAD-box RNA Helicases | 2 | 2022 | 383 | 0.190 |
Why?
|
Wilms Tumor | 1 | 2024 | 376 | 0.190 |
Why?
|
In Situ Hybridization, Fluorescence | 8 | 2019 | 2500 | 0.190 |
Why?
|
MAP Kinase Signaling System | 4 | 2019 | 1483 | 0.190 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 84 | 0.190 |
Why?
|
Transducin | 1 | 2020 | 42 | 0.180 |
Why?
|
Survival Rate | 13 | 2021 | 12806 | 0.180 |
Why?
|
Sarcoma | 3 | 2022 | 1786 | 0.180 |
Why?
|
Multigene Family | 3 | 2013 | 1079 | 0.180 |
Why?
|
Retrospective Studies | 29 | 2024 | 80301 | 0.180 |
Why?
|
Neurogenesis | 3 | 2019 | 855 | 0.180 |
Why?
|
Aged | 44 | 2021 | 168995 | 0.180 |
Why?
|
Lymphopenia | 1 | 2022 | 280 | 0.180 |
Why?
|
Antigens | 1 | 2006 | 1447 | 0.180 |
Why?
|
SOXB1 Transcription Factors | 3 | 2014 | 286 | 0.180 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 429 | 0.180 |
Why?
|
Clinical Trials as Topic | 6 | 2024 | 8058 | 0.180 |
Why?
|
Pathology, Molecular | 2 | 2022 | 330 | 0.180 |
Why?
|
Epigenesis, Genetic | 8 | 2022 | 3758 | 0.180 |
Why?
|
Infant | 20 | 2024 | 36030 | 0.180 |
Why?
|
MicroRNAs | 4 | 2019 | 3784 | 0.170 |
Why?
|
Brain | 12 | 2022 | 26912 | 0.170 |
Why?
|
Young Adult | 26 | 2022 | 58673 | 0.170 |
Why?
|
Brain Edema | 2 | 2020 | 603 | 0.170 |
Why?
|
Cell Cycle Proteins | 7 | 2024 | 3448 | 0.170 |
Why?
|
Neuroglia | 2 | 2019 | 944 | 0.170 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2020 | 612 | 0.170 |
Why?
|
Immunohistochemistry | 16 | 2020 | 11064 | 0.170 |
Why?
|
Karyopherins | 2 | 2024 | 130 | 0.170 |
Why?
|
Cell Size | 1 | 2021 | 623 | 0.170 |
Why?
|
DNA Damage | 4 | 2022 | 2442 | 0.170 |
Why?
|
Spinal Cord | 4 | 2016 | 1817 | 0.170 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 343 | 0.170 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2018 | 184 | 0.170 |
Why?
|
Angiogenesis Inhibitors | 4 | 2019 | 2047 | 0.170 |
Why?
|
Chromosome Deletion | 3 | 2015 | 1387 | 0.170 |
Why?
|
Zebrafish Proteins | 3 | 2012 | 1006 | 0.170 |
Why?
|
DNA-Binding Proteins | 6 | 2012 | 9590 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 896 | 0.160 |
Why?
|
Aged, 80 and over | 22 | 2021 | 58947 | 0.160 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2018 | 50 | 0.160 |
Why?
|
Protein Folding | 1 | 2023 | 867 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 18 | 2020 | 36247 | 0.160 |
Why?
|
Testicular Neoplasms | 3 | 2015 | 800 | 0.160 |
Why?
|
Dictionaries as Topic | 1 | 2018 | 11 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 10 | 2021 | 6545 | 0.160 |
Why?
|
Cell Enlargement | 1 | 2018 | 60 | 0.160 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2024 | 435 | 0.160 |
Why?
|
Ganglioglioma | 1 | 2018 | 36 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2024 | 454 | 0.160 |
Why?
|
Retina | 1 | 2009 | 2635 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 68 | 0.160 |
Why?
|
Survival Analysis | 10 | 2023 | 10185 | 0.160 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 123 | 0.160 |
Why?
|
Dexamethasone | 3 | 2020 | 1928 | 0.160 |
Why?
|
Pyrroles | 2 | 2015 | 1137 | 0.160 |
Why?
|
Carcinoma, Medullary | 1 | 2019 | 115 | 0.160 |
Why?
|
Rad51 Recombinase | 1 | 2019 | 188 | 0.150 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2021 | 717 | 0.150 |
Why?
|
Stathmin | 1 | 2018 | 70 | 0.150 |
Why?
|
Autopsy | 2 | 2019 | 1007 | 0.150 |
Why?
|
Choroid Plexus Neoplasms | 2 | 2016 | 38 | 0.150 |
Why?
|
Alleles | 5 | 2019 | 6900 | 0.150 |
Why?
|
Mutagenesis | 2 | 2020 | 1234 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2008 | 52 | 0.150 |
Why?
|
Neoplasm Transplantation | 6 | 2019 | 2014 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 753 | 0.150 |
Why?
|
Epilepsy | 3 | 2024 | 3267 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2022 | 368 | 0.150 |
Why?
|
Apoptosis | 10 | 2024 | 9497 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 515 | 0.150 |
Why?
|
Transaminases | 1 | 2018 | 196 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2021 | 15766 | 0.150 |
Why?
|
Pyridazines | 1 | 2019 | 200 | 0.150 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 786 | 0.150 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2003 | 0.150 |
Why?
|
Databases, Protein | 1 | 2019 | 388 | 0.150 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2017 | 34 | 0.140 |
Why?
|
Azetidines | 1 | 2018 | 137 | 0.140 |
Why?
|
Cyclin G1 | 1 | 2017 | 15 | 0.140 |
Why?
|
Cell Survival | 9 | 2024 | 5796 | 0.140 |
Why?
|
Methionine | 2 | 2022 | 569 | 0.140 |
Why?
|
Chromatin | 4 | 2022 | 2939 | 0.140 |
Why?
|
Activin Receptors, Type I | 2 | 2016 | 136 | 0.140 |
Why?
|
Azepines | 1 | 2019 | 330 | 0.140 |
Why?
|
Disease Progression | 10 | 2021 | 13505 | 0.140 |
Why?
|
Proteostasis Deficiencies | 1 | 2017 | 39 | 0.140 |
Why?
|
Mice, Transgenic | 9 | 2020 | 9531 | 0.140 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2019 | 347 | 0.140 |
Why?
|
raf Kinases | 1 | 2017 | 118 | 0.140 |
Why?
|
Vinblastine | 1 | 2018 | 487 | 0.140 |
Why?
|
Heterocyclic Compounds, 3-Ring | 2 | 2017 | 275 | 0.140 |
Why?
|
Mice, Inbred C57BL | 8 | 2020 | 22025 | 0.140 |
Why?
|
Interleukin-12 | 1 | 2019 | 584 | 0.140 |
Why?
|
Micro-Electrical-Mechanical Systems | 1 | 2016 | 31 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2019 | 256 | 0.140 |
Why?
|
Myelin Sheath | 3 | 2012 | 651 | 0.140 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
Repressor Proteins | 2 | 2019 | 2978 | 0.140 |
Why?
|
Myxoma | 1 | 2017 | 114 | 0.140 |
Why?
|
Genes, p53 | 2 | 2009 | 714 | 0.130 |
Why?
|
Nuclear Proteins | 7 | 2024 | 5793 | 0.130 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 2 | 2016 | 76 | 0.130 |
Why?
|
Enzyme Activation | 3 | 2019 | 3604 | 0.130 |
Why?
|
Glutamic Acid | 2 | 2019 | 1166 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2024 | 949 | 0.130 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1388 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2021 | 1090 | 0.130 |
Why?
|
Imidazolines | 1 | 2015 | 18 | 0.130 |
Why?
|
Treatment Outcome | 20 | 2023 | 64947 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2018 | 3618 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2019 | 1314 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 912 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2016 | 2449 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1132 | 0.130 |
Why?
|
Follow-Up Studies | 15 | 2020 | 39254 | 0.130 |
Why?
|
Medical Tourism | 1 | 2016 | 52 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2017 | 1244 | 0.130 |
Why?
|
Protein Isoforms | 1 | 2020 | 1697 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 193 | 0.130 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 854 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2018 | 772 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2017 | 210 | 0.130 |
Why?
|
Promoter Regions, Genetic | 9 | 2021 | 5784 | 0.130 |
Why?
|
Olfaction Disorders | 1 | 2018 | 224 | 0.130 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2018 | 345 | 0.130 |
Why?
|
Cohort Studies | 16 | 2022 | 41317 | 0.130 |
Why?
|
Tissue Distribution | 3 | 2015 | 2262 | 0.130 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2015 | 32 | 0.120 |
Why?
|
Synteny | 1 | 2015 | 77 | 0.120 |
Why?
|
Cell Growth Processes | 2 | 2014 | 384 | 0.120 |
Why?
|
Peptides | 2 | 2019 | 4358 | 0.120 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 114 | 0.120 |
Why?
|
Gossypol | 1 | 2014 | 23 | 0.120 |
Why?
|
Glial Fibrillary Acidic Protein | 4 | 2012 | 550 | 0.120 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 3613 | 0.120 |
Why?
|
Hyperglycemia | 1 | 2023 | 1380 | 0.120 |
Why?
|
Tumor Cells, Cultured | 6 | 2019 | 6131 | 0.120 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4312 | 0.120 |
Why?
|
Seizures | 4 | 2024 | 2916 | 0.120 |
Why?
|
Cells, Cultured | 13 | 2018 | 18968 | 0.120 |
Why?
|
Interferon-gamma | 2 | 2020 | 3160 | 0.120 |
Why?
|
Oxadiazoles | 1 | 2014 | 94 | 0.120 |
Why?
|
Adenoma, Oxyphilic | 1 | 2016 | 148 | 0.120 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 490 | 0.120 |
Why?
|
Cell Nucleus | 3 | 2017 | 2909 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 475 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10183 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1999 | 0.120 |
Why?
|
Point Mutation | 2 | 2017 | 1594 | 0.120 |
Why?
|
Neoplasm Staging | 9 | 2015 | 11141 | 0.120 |
Why?
|
Loss of Heterozygosity | 2 | 2014 | 659 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.110 |
Why?
|
Software | 2 | 2021 | 4420 | 0.110 |
Why?
|
DNA Helicases | 4 | 2024 | 854 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 3 | 2013 | 1356 | 0.110 |
Why?
|
Algorithms | 7 | 2019 | 13967 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 718 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1093 | 0.110 |
Why?
|
Disease Models, Animal | 11 | 2022 | 18134 | 0.110 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 796 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1178 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 385 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1008 | 0.110 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1354 | 0.110 |
Why?
|
Octamer Transcription Factor-3 | 3 | 2014 | 223 | 0.110 |
Why?
|
Connexin 43 | 1 | 2014 | 200 | 0.110 |
Why?
|
Epitopes | 1 | 2019 | 2506 | 0.110 |
Why?
|
Disease-Free Survival | 8 | 2016 | 6830 | 0.110 |
Why?
|
Gene Deletion | 4 | 2015 | 2668 | 0.110 |
Why?
|
Gene Frequency | 1 | 2020 | 3605 | 0.110 |
Why?
|
Gene Amplification | 2 | 2014 | 1085 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2020 | 978 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3531 | 0.110 |
Why?
|
Acrylamides | 1 | 2014 | 260 | 0.110 |
Why?
|
Genes, Duplicate | 1 | 2012 | 30 | 0.100 |
Why?
|
Somatostatin | 1 | 2014 | 447 | 0.100 |
Why?
|
Immunoenzyme Techniques | 6 | 2015 | 1705 | 0.100 |
Why?
|
Optic Nerve Glioma | 1 | 2012 | 32 | 0.100 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2012 | 71 | 0.100 |
Why?
|
Karnofsky Performance Status | 3 | 2019 | 165 | 0.100 |
Why?
|
Decision Trees | 1 | 2014 | 506 | 0.100 |
Why?
|
Models, Biological | 5 | 2021 | 9468 | 0.100 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2012 | 74 | 0.100 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2016 | 432 | 0.100 |
Why?
|
Mass Spectrometry | 3 | 2014 | 2192 | 0.100 |
Why?
|
Protein Multimerization | 1 | 2017 | 983 | 0.100 |
Why?
|
Hydroxamic Acids | 1 | 2015 | 482 | 0.100 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2012 | 81 | 0.100 |
Why?
|
DNA Fragmentation | 1 | 2012 | 237 | 0.100 |
Why?
|
Phenotype | 5 | 2020 | 16543 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1478 | 0.100 |
Why?
|
Glycine | 1 | 2015 | 663 | 0.100 |
Why?
|
Coculture Techniques | 1 | 2015 | 1340 | 0.100 |
Why?
|
Immunomodulation | 1 | 2015 | 547 | 0.100 |
Why?
|
Mice, SCID | 4 | 2016 | 2627 | 0.100 |
Why?
|
Spectrum Analysis, Raman | 1 | 2013 | 234 | 0.100 |
Why?
|
3T3 Cells | 1 | 2013 | 1085 | 0.100 |
Why?
|
Cluster Analysis | 6 | 2019 | 2698 | 0.100 |
Why?
|
bcl-2-Associated X Protein | 1 | 2012 | 282 | 0.090 |
Why?
|
Phosphorylation | 7 | 2018 | 8314 | 0.090 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1044 | 0.090 |
Why?
|
Combined Modality Therapy | 7 | 2020 | 8551 | 0.090 |
Why?
|
Genotype | 6 | 2016 | 12959 | 0.090 |
Why?
|
Salvage Therapy | 1 | 2017 | 1266 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 346 | 0.090 |
Why?
|
Lysine | 3 | 2020 | 1002 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 850 | 0.090 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21065 | 0.090 |
Why?
|
Multipotent Stem Cells | 2 | 2009 | 200 | 0.090 |
Why?
|
Neurofibromatosis 1 | 2 | 2012 | 561 | 0.090 |
Why?
|
Intraoperative Care | 1 | 2014 | 768 | 0.090 |
Why?
|
Paraffin Embedding | 1 | 2011 | 302 | 0.090 |
Why?
|
Cell Line | 9 | 2019 | 15626 | 0.090 |
Why?
|
Genetic Loci | 2 | 2019 | 2618 | 0.090 |
Why?
|
Predictive Value of Tests | 8 | 2021 | 15273 | 0.090 |
Why?
|
HMGB Proteins | 2 | 2007 | 44 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3774 | 0.090 |
Why?
|
Models, Genetic | 2 | 2011 | 3442 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 358 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2021 | 2825 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2014 | 1767 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2058 | 0.090 |
Why?
|
Malformations of Cortical Development | 1 | 2012 | 177 | 0.090 |
Why?
|
Formaldehyde | 1 | 2011 | 358 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1120 | 0.080 |
Why?
|
Enzyme Inhibitors | 3 | 2022 | 3726 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1423 | 0.080 |
Why?
|
Diagnosis, Differential | 8 | 2018 | 12968 | 0.080 |
Why?
|
Proteome | 1 | 2019 | 1856 | 0.080 |
Why?
|
Neuronavigation | 1 | 2011 | 164 | 0.080 |
Why?
|
Dioxygenases | 1 | 2012 | 343 | 0.080 |
Why?
|
Autoantigens | 1 | 2014 | 877 | 0.080 |
Why?
|
NF-kappa B | 1 | 2018 | 2486 | 0.080 |
Why?
|
Base Sequence | 9 | 2014 | 12447 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1837 | 0.080 |
Why?
|
DNA Transposable Elements | 1 | 2013 | 752 | 0.080 |
Why?
|
Heat-Shock Response | 2 | 2023 | 179 | 0.080 |
Why?
|
Receptor, TIE-2 | 2 | 2019 | 177 | 0.080 |
Why?
|
Reproducibility of Results | 9 | 2023 | 20048 | 0.080 |
Why?
|
Gene Expression Regulation | 5 | 2019 | 11902 | 0.080 |
Why?
|
Mice, Knockout | 6 | 2020 | 14396 | 0.080 |
Why?
|
CpG Islands | 1 | 2013 | 1221 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2363 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1956 | 0.080 |
Why?
|
Tumor Burden | 3 | 2023 | 1897 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1729 | 0.080 |
Why?
|
Histone Demethylases | 2 | 2023 | 323 | 0.080 |
Why?
|
Microscopy | 1 | 2013 | 881 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1977 | 0.080 |
Why?
|
Cytokines | 3 | 2019 | 7345 | 0.080 |
Why?
|
Electroencephalography | 2 | 2022 | 6182 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2022 | 311 | 0.070 |
Why?
|
Pyrimidines | 3 | 2022 | 3011 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1601 | 0.070 |
Why?
|
Image Enhancement | 1 | 2018 | 2877 | 0.070 |
Why?
|
Medical Oncology | 1 | 2019 | 2321 | 0.070 |
Why?
|
Genes, myc | 1 | 2009 | 395 | 0.070 |
Why?
|
Microvessels | 1 | 2012 | 572 | 0.070 |
Why?
|
Embryonic Development | 1 | 2012 | 712 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3606 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 728 | 0.070 |
Why?
|
Crosses, Genetic | 1 | 2008 | 751 | 0.070 |
Why?
|
Diacylglycerol Kinase | 1 | 2007 | 48 | 0.070 |
Why?
|
Thiazoles | 1 | 2014 | 1509 | 0.070 |
Why?
|
Helix-Loop-Helix Motifs | 3 | 1996 | 96 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 6 | 2016 | 17766 | 0.070 |
Why?
|
Zebrafish | 2 | 2023 | 2996 | 0.070 |
Why?
|
RNA, Messenger | 5 | 2017 | 12762 | 0.070 |
Why?
|
Green Fluorescent Proteins | 3 | 2010 | 2056 | 0.070 |
Why?
|
Polymerase Chain Reaction | 6 | 2015 | 6067 | 0.070 |
Why?
|
Drug Design | 1 | 2012 | 1062 | 0.070 |
Why?
|
GTP-Binding Proteins | 1 | 2011 | 951 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2020 | 10829 | 0.070 |
Why?
|
Neovascularization, Pathologic | 3 | 2012 | 2641 | 0.070 |
Why?
|
Bromodeoxyuridine | 1 | 2007 | 310 | 0.070 |
Why?
|
World Health Organization | 2 | 2023 | 1319 | 0.070 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2007 | 112 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2148 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1548 | 0.070 |
Why?
|
Phospholipids | 1 | 2010 | 789 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5206 | 0.070 |
Why?
|
Leukomalacia, Periventricular | 1 | 2008 | 184 | 0.070 |
Why?
|
Bayes Theorem | 3 | 2023 | 2325 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1523 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1634 | 0.070 |
Why?
|
Time Factors | 6 | 2019 | 40133 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2013 | 941 | 0.070 |
Why?
|
Ischemia | 1 | 2015 | 1893 | 0.070 |
Why?
|
Methylation | 2 | 2020 | 1080 | 0.070 |
Why?
|
HEK293 Cells | 4 | 2022 | 4264 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3800 | 0.070 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2007 | 313 | 0.070 |
Why?
|
Germ-Line Mutation | 2 | 2017 | 1843 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1401 | 0.060 |
Why?
|
Binding Sites | 4 | 2014 | 6050 | 0.060 |
Why?
|
Feedback, Physiological | 1 | 2008 | 476 | 0.060 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2005 | 24 | 0.060 |
Why?
|
Quantum Dots | 1 | 2007 | 168 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3731 | 0.060 |
Why?
|
Luciferases | 1 | 2007 | 716 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3696 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6540 | 0.060 |
Why?
|
Contrast Media | 1 | 2018 | 5301 | 0.060 |
Why?
|
Flow Cytometry | 3 | 2017 | 5873 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 3076 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2526 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2014 | 1614 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1083 | 0.060 |
Why?
|
Immunoblotting | 3 | 2012 | 1649 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 696 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 120 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6030 | 0.060 |
Why?
|
Piperazines | 3 | 2009 | 2520 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 859 | 0.060 |
Why?
|
Radiography | 3 | 2014 | 6965 | 0.060 |
Why?
|
Ectoderm | 1 | 2004 | 136 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 724 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 3 | 2012 | 1056 | 0.060 |
Why?
|
Wnt Proteins | 2 | 2009 | 718 | 0.060 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3526 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2006 | 351 | 0.060 |
Why?
|
Blotting, Western | 4 | 2015 | 5039 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2022 | 1755 | 0.060 |
Why?
|
Molecular Sequence Data | 8 | 2014 | 17628 | 0.060 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 865 | 0.060 |
Why?
|
Telomere | 2 | 2023 | 934 | 0.050 |
Why?
|
Hyperargininemia | 1 | 2003 | 12 | 0.050 |
Why?
|
Claudins | 1 | 2024 | 115 | 0.050 |
Why?
|
Wnt1 Protein | 1 | 2003 | 120 | 0.050 |
Why?
|
Endpoint Determination | 2 | 2017 | 597 | 0.050 |
Why?
|
Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
Galectin 1 | 1 | 2023 | 128 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2019 | 544 | 0.050 |
Why?
|
Patient Selection | 1 | 2014 | 4276 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2017 | 8945 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2016 | 4938 | 0.050 |
Why?
|
Brain Mapping | 2 | 2016 | 6562 | 0.050 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2002 | 84 | 0.050 |
Why?
|
Open Reading Frames | 2 | 2024 | 814 | 0.050 |
Why?
|
RNA Interference | 3 | 2019 | 2846 | 0.050 |
Why?
|
Up-Regulation | 4 | 2019 | 4127 | 0.050 |
Why?
|
Stereotaxic Techniques | 2 | 2016 | 549 | 0.050 |
Why?
|
Gene Expression | 2 | 2014 | 7592 | 0.050 |
Why?
|
Isoenzymes | 1 | 2006 | 1690 | 0.050 |
Why?
|
Maximum Tolerated Dose | 2 | 2018 | 877 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2014 | 1945 | 0.050 |
Why?
|
Mesoderm | 2 | 1995 | 671 | 0.050 |
Why?
|
Computational Biology | 3 | 2020 | 3504 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 413 | 0.050 |
Why?
|
Homozygote | 2 | 2023 | 1786 | 0.050 |
Why?
|
Sensitivity and Specificity | 6 | 2015 | 14656 | 0.050 |
Why?
|
Nervous System | 2 | 2022 | 543 | 0.050 |
Why?
|
Consensus | 2 | 2023 | 3106 | 0.050 |
Why?
|
Brain Stem | 2 | 2017 | 857 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 1246 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3530 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2024 | 495 | 0.050 |
Why?
|
International Agencies | 2 | 2012 | 244 | 0.050 |
Why?
|
Neurofibromin 1 | 2 | 2012 | 190 | 0.050 |
Why?
|
Protein Binding | 4 | 2014 | 9336 | 0.050 |
Why?
|
High-Throughput Screening Assays | 2 | 2017 | 943 | 0.050 |
Why?
|
Vaccinia virus | 1 | 2022 | 332 | 0.050 |
Why?
|
Transcription, Genetic | 5 | 2020 | 7593 | 0.050 |
Why?
|
RNA | 2 | 2024 | 2721 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2016 | 6499 | 0.050 |
Why?
|
Pathology, Clinical | 1 | 2024 | 375 | 0.050 |
Why?
|
Motor Neurons | 1 | 2006 | 865 | 0.050 |
Why?
|
Genetic Markers | 3 | 2015 | 2608 | 0.050 |
Why?
|
Lipids | 1 | 2011 | 3336 | 0.040 |
Why?
|
Methylnitrosourea | 1 | 2020 | 24 | 0.040 |
Why?
|
Ki-67 Antigen | 2 | 2016 | 631 | 0.040 |
Why?
|
Caspase 3 | 2 | 2016 | 730 | 0.040 |
Why?
|
Skin Neoplasms | 2 | 2018 | 5797 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6226 | 0.040 |
Why?
|
Gene Silencing | 2 | 2020 | 1511 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2006 | 1341 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 616 | 0.040 |
Why?
|
Feedback | 1 | 2023 | 791 | 0.040 |
Why?
|
Blood-Brain Barrier | 2 | 2017 | 1017 | 0.040 |
Why?
|
Glutamine | 1 | 2003 | 576 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2056 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
Transgenes | 1 | 2003 | 1006 | 0.040 |
Why?
|
Melanoma | 1 | 2018 | 5695 | 0.040 |
Why?
|
STAT3 Transcription Factor | 2 | 2016 | 877 | 0.040 |
Why?
|
Collagen Type I | 1 | 2023 | 615 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2019 | 81 | 0.040 |
Why?
|
Equipment Design | 2 | 2018 | 3520 | 0.040 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 1415 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
Infant, Newborn | 5 | 2024 | 26168 | 0.040 |
Why?
|
Cranial Irradiation | 2 | 2015 | 391 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 995 | 0.040 |
Why?
|
Biphenyl Compounds | 2 | 2014 | 988 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2018 | 2536 | 0.040 |
Why?
|
Hyperplasia | 2 | 2012 | 1158 | 0.040 |
Why?
|
Prospective Studies | 4 | 2020 | 54263 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2394 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2023 | 1493 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2020 | 333 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2023 | 2473 | 0.040 |
Why?
|
Twins | 1 | 2020 | 339 | 0.040 |
Why?
|
Prosencephalon | 1 | 2020 | 305 | 0.040 |
Why?
|
Propensity Score | 2 | 2017 | 1918 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9196 | 0.040 |
Why?
|
CDC2 Protein Kinase | 1 | 2019 | 213 | 0.040 |
Why?
|
Organ Specificity | 2 | 2013 | 1955 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4024 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
S Phase | 1 | 2019 | 422 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2023 | 730 | 0.040 |
Why?
|
Tumor Escape | 1 | 2021 | 371 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2018 | 169 | 0.040 |
Why?
|
DNA Repair | 2 | 2018 | 2039 | 0.040 |
Why?
|
Proteomics | 2 | 2024 | 3810 | 0.040 |
Why?
|
Diencephalon | 1 | 2017 | 54 | 0.040 |
Why?
|
Gamma Rays | 1 | 2019 | 317 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 591 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4044 | 0.040 |
Why?
|
Frozen Sections | 2 | 2015 | 153 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 293 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
Regeneration | 1 | 2006 | 1506 | 0.040 |
Why?
|
Necrosis | 2 | 2015 | 1612 | 0.040 |
Why?
|
Adenosine | 1 | 2022 | 833 | 0.040 |
Why?
|
Doxorubicin | 1 | 2024 | 2207 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 929 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2024 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1129 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 541 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9945 | 0.040 |
Why?
|
Receptors, sigma | 1 | 2017 | 45 | 0.040 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2017 | 55 | 0.030 |
Why?
|
Phosphoserine | 1 | 2017 | 203 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12532 | 0.030 |
Why?
|
Fibroblasts | 2 | 2023 | 4091 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 623 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2017 | 122 | 0.030 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 705 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1408 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2024 | 2104 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8487 | 0.030 |
Why?
|
Ependyma | 1 | 2016 | 55 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 87 | 0.030 |
Why?
|
Drug Interactions | 1 | 2020 | 1426 | 0.030 |
Why?
|
Pyridines | 3 | 2014 | 2877 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 558 | 0.030 |
Why?
|
Barrett Esophagus | 1 | 2020 | 490 | 0.030 |
Why?
|
Biopsy | 2 | 2018 | 6775 | 0.030 |
Why?
|
Cell Count | 2 | 2012 | 1838 | 0.030 |
Why?
|
Paraplegia | 1 | 2016 | 162 | 0.030 |
Why?
|
Glycine Dehydrogenase (Decarboxylating) | 1 | 2015 | 15 | 0.030 |
Why?
|
Pyruvaldehyde | 1 | 2015 | 16 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 203 | 0.030 |
Why?
|
Acetone | 1 | 2015 | 44 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2019 | 556 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 555 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 2017 | 265 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2017 | 409 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 892 | 0.030 |
Why?
|
Hippocampus | 1 | 2007 | 3737 | 0.030 |
Why?
|
HeLa Cells | 2 | 2011 | 3105 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 787 | 0.030 |
Why?
|
Chromatiaceae | 1 | 2014 | 5 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3302 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 516 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2016 | 330 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
Chromosome Mapping | 3 | 2013 | 4625 | 0.030 |
Why?
|
Adenovirus E1A Proteins | 1 | 2014 | 73 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 2895 | 0.030 |
Why?
|
Histone Code | 1 | 2015 | 157 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 840 | 0.030 |
Why?
|
Receptors, Somatostatin | 1 | 2014 | 135 | 0.030 |
Why?
|
Hematoxylin | 1 | 2013 | 60 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2013 | 69 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3483 | 0.030 |
Why?
|
Vertebrates | 1 | 1995 | 228 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 729 | 0.030 |
Why?
|
Smad Proteins | 1 | 2014 | 158 | 0.030 |
Why?
|
Embryonic Stem Cells | 2 | 2014 | 1262 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2017 | 656 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1647 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
DNA Restriction Enzymes | 1 | 2013 | 553 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2005 | 2776 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2015 | 190 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1739 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2018 | 4554 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 358 | 0.030 |
Why?
|
Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1765 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1765 | 0.030 |
Why?
|
Myosins | 1 | 1994 | 405 | 0.030 |
Why?
|
Hormones | 1 | 2017 | 867 | 0.030 |
Why?
|
Fetus | 1 | 2020 | 1859 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1870 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 2015 | 402 | 0.030 |
Why?
|
Melanophores | 1 | 2012 | 16 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1811 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3277 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 195 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2015 | 514 | 0.030 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2015 | 330 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2015 | 657 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2014 | 900 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2014 | 321 | 0.030 |
Why?
|
Microspheres | 1 | 2015 | 785 | 0.030 |
Why?
|
Color | 1 | 2013 | 298 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2222 | 0.030 |
Why?
|
Cytoplasm | 1 | 2017 | 1518 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2874 | 0.030 |
Why?
|
Gene Library | 1 | 2015 | 1060 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 444 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 375 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1635 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2023 | 2218 | 0.020 |
Why?
|
Cerebellum | 1 | 2019 | 1495 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 704 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 282 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2012 | 6242 | 0.020 |
Why?
|
Steroids | 1 | 2017 | 928 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2204 | 0.020 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 270 | 0.020 |
Why?
|
Dimethyl Sulfoxide | 1 | 2012 | 252 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18415 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2012 | 263 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 2013 | 188 | 0.020 |
Why?
|
Procarbazine | 1 | 2011 | 172 | 0.020 |
Why?
|
Schwann Cells | 1 | 2012 | 196 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 563 | 0.020 |
Why?
|
Lomustine | 1 | 2011 | 60 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 561 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2013 | 534 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 734 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1720 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2010 | 4900 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2012 | 193 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2012 | 160 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2011 | 156 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3149 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3723 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2013 | 480 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1122 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1994 | 924 | 0.020 |
Why?
|
Microglia | 1 | 2019 | 1348 | 0.020 |
Why?
|
Larva | 1 | 2012 | 509 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1442 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 939 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2394 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1870 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 373 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1675 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 2012 | 13456 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2012 | 652 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1651 | 0.020 |
Why?
|
Immunity | 1 | 2015 | 998 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1617 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6592 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2015 | 1354 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2014 | 840 | 0.020 |
Why?
|
Vincristine | 1 | 2011 | 1038 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2015 | 1840 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2391 | 0.020 |
Why?
|
beta Catenin | 1 | 2014 | 1043 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2007 | 1993 | 0.020 |
Why?
|
Molecular Biology | 1 | 2012 | 581 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5745 | 0.020 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2009 | 232 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2651 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2010 | 1544 | 0.020 |
Why?
|
Osteogenesis | 1 | 1995 | 1271 | 0.020 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2008 | 84 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2128 | 0.020 |
Why?
|
Doxycycline | 1 | 2010 | 337 | 0.020 |
Why?
|
Sulfonamides | 2 | 2008 | 1973 | 0.020 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2009 | 117 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2010 | 749 | 0.020 |
Why?
|
Plant Lectins | 1 | 2008 | 103 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5201 | 0.020 |
Why?
|
Codon | 1 | 2009 | 602 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5498 | 0.020 |
Why?
|
Endostatins | 1 | 2008 | 168 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1914 | 0.020 |
Why?
|
Carcinoma, Embryonal | 1 | 2007 | 37 | 0.020 |
Why?
|
Kidney | 2 | 2019 | 7072 | 0.020 |
Why?
|
Thrombospondins | 1 | 2008 | 193 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4044 | 0.020 |
Why?
|
Aging | 1 | 2006 | 8641 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 2277 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3305 | 0.020 |
Why?
|
Diverticulitis | 1 | 2010 | 178 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 867 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2596 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2852 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2441 | 0.020 |
Why?
|
Vimentin | 1 | 2008 | 255 | 0.020 |
Why?
|
Pluripotent Stem Cells | 1 | 2014 | 791 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1920 | 0.020 |
Why?
|
ras Proteins | 1 | 2012 | 1051 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2508 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7803 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3433 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 2007 | 418 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2007 | 326 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22041 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 282 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1884 | 0.020 |
Why?
|
Streptozocin | 1 | 2006 | 193 | 0.020 |
Why?
|
Seminoma | 1 | 2007 | 134 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2006 | 122 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2008 | 590 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2544 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1760 | 0.020 |
Why?
|
Microdissection | 1 | 2005 | 151 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 3969 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2012 | 2897 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2819 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2006 | 1304 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4404 | 0.020 |
Why?
|
Lectins | 1 | 2006 | 485 | 0.010 |
Why?
|
Neutropenia | 1 | 2010 | 884 | 0.010 |
Why?
|
Skin | 1 | 2018 | 4468 | 0.010 |
Why?
|
Adipokines | 1 | 2006 | 311 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10340 | 0.010 |
Why?
|
Species Specificity | 1 | 2009 | 2413 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2014 | 2563 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2249 | 0.010 |
Why?
|
Radiotherapy | 1 | 2011 | 1505 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1737 | 0.010 |
Why?
|
Integrases | 1 | 2006 | 516 | 0.010 |
Why?
|
Benzamides | 1 | 2009 | 1369 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3491 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3421 | 0.010 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2007 | 329 | 0.010 |
Why?
|
United States | 3 | 2018 | 72363 | 0.010 |
Why?
|
Amino Acids, Basic | 1 | 2003 | 9 | 0.010 |
Why?
|
Rhabdomyosarcoma | 1 | 2006 | 361 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8157 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2007 | 567 | 0.010 |
Why?
|
Survivors | 1 | 2014 | 2367 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2696 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5429 | 0.010 |
Why?
|
DNA | 1 | 2017 | 7236 | 0.010 |
Why?
|
Arginase | 1 | 2003 | 80 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1733 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2007 | 1553 | 0.010 |
Why?
|
Thalidomide | 1 | 2008 | 884 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2016 | 3127 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1078 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 1130 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6310 | 0.010 |
Why?
|
Motor Activity | 1 | 2012 | 2687 | 0.010 |
Why?
|
Ammonia | 1 | 2003 | 236 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8553 | 0.010 |
Why?
|
Transformation, Genetic | 1 | 2002 | 193 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2010 | 1174 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5782 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2138 | 0.010 |
Why?
|
Infusion Pumps, Implantable | 1 | 2002 | 157 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2378 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12156 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6181 | 0.010 |
Why?
|
Carcinoma, Basal Cell | 1 | 2006 | 559 | 0.010 |
Why?
|
Pedigree | 1 | 2009 | 4577 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2006 | 1437 | 0.010 |
Why?
|
Heart | 1 | 2014 | 4392 | 0.010 |
Why?
|
Models, Neurological | 1 | 2009 | 1758 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4891 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2415 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3443 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4437 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 850 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2002 | 835 | 0.010 |
Why?
|
Arginine | 1 | 2003 | 934 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10530 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2007 | 1740 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3587 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29725 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6457 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15687 | 0.010 |
Why?
|
Oxygen | 1 | 2009 | 4189 | 0.010 |
Why?
|
Pyrazoles | 1 | 2008 | 1992 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74269 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 1996 | 104 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2003 | 1802 | 0.010 |
Why?
|
Connective Tissue | 1 | 1995 | 416 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1995 | 1765 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1993 | 761 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4172 | 0.010 |
Why?
|
Liver | 1 | 2003 | 7512 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4923 | 0.000 |
Why?
|